Gardasil Generated $10 Mil. In First 11 Days On The Market
Merck will pay royalties of between 24%-26% of worldwide sales of Gardasil in the aggregate, including payments to CSL Limited relating to technology used in the human papillomavirus vaccine
Merck will pay royalties of between 24%-26% of worldwide sales of Gardasil in the aggregate, including payments to CSL Limited relating to technology used in the human papillomavirus vaccine